← Eichor
Study identifier: NCT06476678 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Novel Bipolar Radiofrequency Ablation Knife in Esophageal Lesions

Condition: Esophageal Neoplasm · Esophageal Polyp · Endoscopic Submucosal Dissection  ·  Sponsor: Baylor College of Medicine

PhaseN/A
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Both Baylor St Luke's Medical Center and Mayo Scottsdale are considered endoscopic submucosal dissection (ESD) centers of excellence. The investigators at Baylor College of Medicine have previously reported our Esophageal ESD experience using the monopolar current knife. Moreover, the research team have previously reported on the clinical efficacy of the bipolar RFA knife during per-oral endoscopic myotomy (POEM) and colonic ESD. The goal of our study is to prospectively evaluate the efficacy, safety and feasibility of Esophageal ESD using a novel Bipolar-Current ESD device.

This description comes directly from the study's public registry record.

Talk to the study team

Salmaan A Jawaid, MD  ·  7137980950  ·  Salmaan.Jawaid@bcm.edu

Haydee Rochits Cueto  ·  7137983606  ·  Haydee.RochitsCueto@bcm.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Baylor College of MedicineHouston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06476678